Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Advancing CLL treatment: A comprehensive look at 1L strategies

Thursday 14 November 2024,
20:00-21:15 (CET)

Renowned international experts come together to discuss the strategies in the treatment of 1L CLL. In this live webinar these strategies will be discussed based on real-world patient cases, where experts from The Netherlands, Germany and Denmark share their views and recommendations.

Subsequently, the highlights from the European Initiative on CLL (ERIC) International Meeting, New Frontiers in CLL Research  (26-28 Sept ’24) will be shared.

Finally, the experts will provide recommendations for the 66th American Society of Hematology (ASH) annual meeting (7-10 Dec ’24).

Q&A will be available throughout the webinar, where the experts answer questions from the audience. This webinar is a must attend for hematologists, oncologists and other healthcare professionals interested in CLL.

International live webinar

Accreditation (for Dutch attendees) has been requested (NIV & VSR).

Program

Prof. Arnon Kater (chair)

Hematologist and professor of Translational Hematology at Amsterdam UMC, The Netherlands

Prof. Barbara Eichhorst

Hematologist/oncologist and professor at the University Hospital Cologne, Cologne, Germany

Carsten Niemann

Hematologist and Clinical Associate professor at Rigshospitalet, Copenhagen, Denmark

Mark-David Levin

Hematologist at Albert Schweitzer Hospital Dordrecht, The Netherlands

Lina van der Straten

Erasmus MC, The Netherlands

Emelie Curovic Rotbain

Rigshospitalet, Denmark

  • 20.00 PM

    Welcome by Prof. Arnon Kater (chair)

    Hier komt je tekst … Selecteer een deel van de tekst om toegang te krijgen tot de opmaak werkbalk.

  • 20.10 PM

    Patient case #1

    Patient case presentation by Lina van der Straten Recommendations/advise provided by expert panel

  • 20.25 PM

    Patient case #2

    Patient case presentation by Emelie Rotbains Recommendations/advise provided by expert panel

  • 20.40 PM

    Patient case #3

    Patient case presentation by Lina van der Straten Recommendations/advise provided by expert panel

  • 20.55 PM

    Post-ERIC highlights / Pre-ASH recommendations

    Highlights/recommendations discussed by expert panel

  • 21.10 PM

    Closure

    Patiënt case presentation by Emelie Rotbains
    Recommendations/advise provided by expert panel

Keep me informed

Would you like to stay informed about this webinar series? Then fill out your information below, and we will send you a message about the registration and topics of the series!

Please enable JavaScript in your browser to complete this form.

Please refer to our privacy statement for more information on how AbbVie processes your personal data, and for a description of your data privacy rights.